Share Email Print

Proceedings Paper

Nonclinical applications of quantitative whole-body autoradiography, and imaging mass spectrometry in drug discovery and development
Author(s): E. G. Solon
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Regulatory agencies require that drug developers characterize the absorption, pharmacokinetics, distribution, metabolism, and elimination (ADME) characteristics of new small and large molecule therapeutic entities. Quantitative whole-body autoradiography (QWBA) has become the definitive tool used for the determining tissue distribution patterns and is specifically requested by the FDA for IND submissions. However, the use of imaging mass spectrometry (IMS) to examine tissue distribution of xenobiotics has quickly gained the attention of pharmaceutical researchers because it does not require the use of radiolabeled test compounds and it can specifically identify the test article and their known metabolites with high imaging resolution. This talk will describe the state-of-the-art of both techniques and present examples of their applications in drug discovery and development.

Paper Details

Date Published: 26 February 2020
PDF: 13 pages
Proc. SPIE 11219, Visualizing and Quantifying Drug Distribution in Tissue IV, 1121903 (26 February 2020); doi: 10.1117/12.2551441
Show Author Affiliations
E. G. Solon, Madrigal Pharmaceuticals, Inc. (United States)

Published in SPIE Proceedings Vol. 11219:
Visualizing and Quantifying Drug Distribution in Tissue IV
Kin Foong Chan; Conor L. Evans, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?